Phosphodiesterase-III Inhibitor Prevents Hemorrhagic Transformation Induced by Focal Cerebral Ischemia in Mice Treated with tPA

The purpose of the present study was to investigate whether cilostazol, a phosphodiesterase-III inhibitor and antiplatelet drug, would prevent tPA-associated hemorrhagic transformation. Mice subjected to 6-h middle cerebral artery occlusion were treated with delayed tPA alone at 6 h, with combined t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Mitsunori, Mishiro, Keisuke, Fujiwara, Yasuyuki, Chen, Huayue, Izuta, Hiroshi, Tsuruma, Kazuhiro, Shimazawa, Masamitsu, Yoshimura, Shinichi, Satoh, Masahiko, Iwama, Toru, Hara, Hideaki
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997776/
https://www.ncbi.nlm.nih.gov/pubmed/21151895
http://dx.doi.org/10.1371/journal.pone.0015178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997776/
https://www.ncbi.nlm.nih.gov/pubmed/21151895
http://dx.doi.org/10.1371/journal.pone.0015178

Ejemplares similares